ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

Philippines secures 25m doses of Sinovac COVID vaccine

Country hopes to inoculate two-thirds of its population this year

The Philippines has secured 25 million doses of COVID-19 vaccines developed by China's Sinovac Biotech, with the first 50,000 expected to arrive in February.   © Reuters

MANILA (Reuters) -- The Philippines has secured 25 million doses of COVID-19 vaccines developed by China's Sinovac Biotech, with the first 50,000 expected to arrive in February, a government official said on Monday.

The deal will be a boost for a country that has among the most coronavirus cases in Asia, but has trailed regional peers in securing vaccines, with which it hopes this year to inoculate 70 million people, or two-thirds of its population.

Presidential Spokesman Harry Roque said the rest of the Sinovac vaccines will arrive in batches from March until December.

The government hopes to vaccinate 50,000 people next month, prioritizing health care workers, Carlito Galvez, a former general in charge of the vaccination procurement effort, told a senate inquiry.

Some senators have expressed concern over delays in the rollout of vaccines, while the government may have difficulties convincing the public of their safety, with a recent survey showing less than a third Filipinos were willing to get inoculated.

Galvez said negotiating with vaccine manufacturers was a "tedious" process and described the global vaccine supply as "very volatile".

The Philippine Food and Drug Administration has yet to approve any COVID-19 vaccines and emergency use authorization applications filed by Pfizer, AstraZeneca and Russia's Gamaleya are pending.

The FDA is still evaluating the late-stage trial applications of Sinovac and Clover.

Singapore began vaccinating health care workers in December, while Indonesia's mass vaccination program is set to start this week. Indonesia on Monday granted emergency use approval to Sinovac's CoronaVac.

The Philippine has secured 30 million doses of the vaccine Covovax from Serum Institute of India, and expects to receive 40 million doses through the COVAX facility in the first quarter.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more